0001493152-23-011249.txt : 20230406 0001493152-23-011249.hdr.sgml : 20230406 20230406162035 ACCESSION NUMBER: 0001493152-23-011249 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230404 FILED AS OF DATE: 20230406 DATE AS OF CHANGE: 20230406 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Morse Robert A. Jr. CENTRAL INDEX KEY: 0001960049 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21617 FILM NUMBER: 23806452 MAIL ADDRESS: STREET 1: 711 STEWART AVENUE STREET 2: SUITE 200 CITY: GARDEN CITY STATE: NY ZIP: 11530 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ProPhase Labs, Inc. CENTRAL INDEX KEY: 0000868278 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232577138 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 711 STEWART AVE, SUITE 200 STREET 2: GARDEN CITY CITY: NEW YORK STATE: NY ZIP: 11530 BUSINESS PHONE: (215) 345-0919 MAIL ADDRESS: STREET 1: 711 STEWART AVE, SUITE 200 STREET 2: GARDEN CITY CITY: NEW YORK STATE: NY ZIP: 11530 FORMER COMPANY: FORMER CONFORMED NAME: QUIGLEY CORP DATE OF NAME CHANGE: 19930328 4 1 ownership.xml X0407 4 2023-04-04 0 0000868278 ProPhase Labs, Inc. PRPH 0001960049 Morse Robert A. Jr. 711 STEWART AVE, SUITE 200 GARDEN CITY, NY 11530 0 1 0 0 CHIEF FINANCIAL OFFICER 0 Option (right to buy) 9.00 2023-04-04 4 A 0 50000 0.00 A 2031-04-03 Common Stock 50000 50000 D The transaction reported in this row involves a grant by the Issuer to the Reporting Person of options to purchase the Issuer's common stock that will vest in five equal annual installments beginning April 5, 2024, subject to the Reporting Person's continued employment with the Issuer on each vesting date. /s/ Robert Morse 2022-04-06